Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cleveland Biolabs Inc (NASDAQ:CBLI)

3.94
Delayed Data
As of Apr 24
 -0.06 / -1.50%
Today’s Change
1.22
Today|||52-Week Range
5.55
+177.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues8.5M3.7M2.7M3.5M
 
 
 
 
 
Depreciation And Amortization471.2K841.0K140.1K63.5K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses30.6M17.2M13.4M9.8M
 
 
 
 
 
Other Operating Expenses0.000.001.1M0.00
 
 
Research And Development19.0M9.6M7.1M6.5M
 
 
 
 
 
Total Operating Expenses31.1M18.1M14.6M9.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-22.6M-14.4M-11.9M-6.4M
 
 
 
 
 
Extraordinary Credit2.9M2.7M0.003.1M
 
 
 
 
Extraordinary Charge-506.2K-33.1K-221.9K0.00
 
 
 
 
Pre-Tax Equity Earnings217.3K-285.5K-362.1K0.00
 
 
 
 
Interest Expense On Debt134.2K1.1M99.5K--
 
 
 
 
Other Expenses0.0013.2M-509.5K402.7K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.1M35.4K-13.0M-2.6M
 
 
 
 
 
Minority Interest-2.9M-1.6M-407.3K-68.8K
 
 
 
 
 
Net Income-17.3M1.6M-12.6M-2.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.3M2.7M7.1M11.0M
 
 
 
 
 
Shares To Calculate EPS Diluted2.3M2.7M7.1M11.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$7.60$12.00-$1.79-$0.24
 
 
 
 
 
EPS Diluted-$7.60$0.60-$1.79-$0.24